We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nine Types of GI Infections Rapidly and Simultaneously Detected

By LabMedica International staff writers
Posted on 06 Apr 2010
A gastrointestinal (GI) panel can detect and differentiate nine types of GI infections simultaneously so that physicians can quickly identify patients who have severe, life-threatening infections.

The nine bacterial pathogens targeted in the GI panel include Clostridium difficile; Clostridium difficile toxin B gene; Campylobacter jejuni; Escherichia coli strain 0157; Listeria monocytogenes; Salmonella enterica; Staphylococcus aureus; Vibrio cholerae; and Vibrio parahaemolyticus.

The panel uses Diatherix Laboratories' (Huntsville, AL, USA) technology--target enriched multiplex polymerase chain reaction (Tem-PCR). More...
Tem-PCR can identify multiple pathogens, detect coinfections, and determine genetic drug resistance in a single result.

"The GI infection C. difficile is becoming more of a hospital threat than [methicillin resistant Staphylococcus aureus] MRSA, and since hospitals are currently limited in their testing methods, this is the ideal time to introduce our new panel," said Dennis Grimaud, chairman and CEO of, Diatherix Laboratories Inc.

The GI panel is the sixth standard testing panel produced by Diatherix. Other panels include tests for infectious disease; Staphylococcus differentiation; respiratory infections; human papillomavirus typing; and respiratory viruses.

Diatherix Laboratories is an emerging leader in infectious disease diagnostics and drug resistance-detection services. Using a multiplexing platform, the company has developed a series of molecular differential diagnostic services that enable speed and accuracy for health care providers in the identification of disease-producing pathogens, leading to appropriate treatment for patients.

Related Links:

Diatherix Laboratories





Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.